Intra-Cellular Therapies, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
2/18/2025
Shares
50,010
Value ($000)
4,177
Weight
0.1%
2022 Q1 - 2024 Q4 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).